Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway
Blood Journal · 18.11.2026
DOI: 10.1182/blood.2026035669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Journal, online erschienen am 18.11.2026. Verfasst von Wanying Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, WuHan, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T-cell therapy can cause immune effector cell-associated neurotoxicity syndrome (ICANS), in which blood-brain barrier (BBB) disruption is a central pathological feature, yet the underlying mechanisms remain poorly understood. Here, we identify indoleamine 2,3-dioxygenase 1 (IDO1)-dependent metabolic reprogramming in cerebrovascular endothelial cells as a mediator linking CAR-T-associated inflammation to BBB dysfunction and neurotoxicity. Patients who developed ICANS exhibited elevated plasma IDO1 activity, a metabolic phenotype recapitulated in a syngeneic CAR-T mouse model characterized by BBB leakage, hippocampal neuronal and synaptic injury, and neurobehavioral impairment. In brain endothelial cells, IDO1 promoted endothelial activation, junctional protein loss, and barrier dysfunction. Pharmacological inhibition and endothelial-specific IDO1 silencing restored barrier integrity and improved neurological outcomes. Mechanistically, IDO1 activation redirected endothelial kynurenine metabolism toward kynureninase (KYNU)-driven anthranilic acid (AA) production, thereby disrupting Wnt/β-catenin-dependent tight junction maintenance. These findings establish the endothelial IDO1-KYNU-AA-Wnt/β-catenin axis as a pathogenic pathway in ICANS and identify endothelial IDO1-dependent metabolism as a potential therapeutic target for preserving BBB integrity and mitigating CAR-T-associated neurotoxicity.
Autor:innen und Institutionen
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, WuHan, China.
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., WuHan, China.
- Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China., XiAn, China.
- Institute of Hematology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Zhong Wu, Yun Kang, Peiru Li, Hekuan Huang, Heng Mei
Zitieren
APA
Zhang, W., Chen, Z., Wang, Z., Wu, J., Gong, Z., Luo, W., Li, C., Zhang, Y., Li, Y., Wu, Z., Kang, Y., Li, P., Shu, J., Su, L., Huang, H., Ren, A., Zhou, F., & Mei, H. (2026). Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway. Blood Journal. https://doi.org/10.1182/blood.2026035669
Vancouver
Zhang W, Chen Z, Wang Z, Wu J, Gong Z, Luo W, et al. Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway. Blood Journal. 2026. doi:10.1182/blood.2026035669
BibTeX
@article{Zhang2026,
author = {Zhang, Wanying and Chen, Zhaozhao and Wang, Zi and Wu, Jianghua and Gong, Zihan and Luo, Wenjing and Li, Chenggong and Zhang, Yinqiang and Li, Yingying and Wu, Zhong and Kang, Yun and Li, Peiru and Shu, Jinhui and Su, Liman and Huang, Hekuan and Ren, Anqi and Zhou, Fen and Mei, Heng},
title = {Endothelial IDO1 Drives BBB Disruption in CAR-T-Associated Neurotoxicity Through KYNU-AA-Wnt/β-catenin Pathway},
journal = {Blood Journal},
year = {2026},
doi = {10.1182/blood.2026035669}
}
EUVIMED